In a study of data from 8,880 patients who had been prescribed an inhaled corticosteroid for the first time, those who received the same type of device for that and their reliever therapy were 15% ...

Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD. Jeffrey D. Dunn, PharmD, MBA: Coming back to what ...

Many current inhalers for conditions such as asthma contain propellants that are potent greenhouse gases. A study from researchers at the University of Cambridge has found that switching to ...

Research has shown that almost half of sufferers do not use their inhaler properly and one in five have missed vital appointments to have their technique checked, according to an Asthma UK survey of ...

Switching from a metered dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a ...

Looking at the prescription data from England in 2017, researchers, including those from the University of Cambridge in the UK, collated the carbon footprint data on inhalers -- commonly used for ...

This article was originally published on October 30, 2019. We are republishing it today following the announcement of a new 'green' metered-dose asthma inhaler A common cold will leave most people ...

The current aerosol asthma inhalers we use are cheap but, because of the gases they contain, are one of the NHS's biggest contributions to climate change. Other countries think alternatives are ...

World COPD Day is celebrated annually on the third Wednesday of November. This day aims to raise awareness about chronic obstructive pulmonary disease (COPD) and encourages better prevention and ...

Inhaler colors often are used to identify specific types of inhalers (such as blue for rescue inhalers) that deliver medication into your lungs to improve breathing. There is no color coding of ...

Although most Medicare Part D plans cover guideline-recommended outpatient chronic obstructive pulmonary disease (COPD) inhalers, the utilization controls applied to these therapies vary by plan type.